Olmesartan Medoxomil

CHEMBL1200692 Phase 4 Zugelassen Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

558.6 g/mol

LogP

3.8

Phase

4

An angiotensin II receptor blocker (ARB) used to treat high blood pressure by blocking the receptor that causes blood vessels to constrict. Relaxing blood vessels reduces the risk of heart attack, stroke, and kidney damage associated with hypertension.

Molekularmasse

558,6000 g/mol

LogP

3,80

TPSA

154,00 Å²

Lipinski-Regel der Fünf

Bestanden

Therapeutische Bereiche

Ovarian Cancer Chronic Kidney Disease Stroke Hyperlipidemia Obesity Type 2 Diabetes Hypertension Heart Failure Atrial Fibrillation Cardiovascular Disease

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D-Struktur

SVG PNG

Cite this structure

Embed this structure

SMILES

CCCc1nc(C(C)(C)O)c(C(=O)OCc2oc(=O)oc2C)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

InChI

InChI=1S/C29H30N6O6/c1-5-8-23-30-25(29(3,4)38)24(27(36)39-16-22-17(2)40-28(37)41-22)35(23)15-18-11-13-19(14-12-18)20-9-6-7-10-21(20)26-31-33-34-32-26/h6-7,9-14,38H,5,8,15-16H2,1-4H3,(H,31,32,33,34)

Molecular Formula

C29H30N6O6

HBD / HBA

2 / 10

Rotierbare Bindungen

11

Schwere Atome

41

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

An angiotensin II receptor blocker (ARB) used to treat high blood pressure by blocking the receptor that causes blood vessels to constrict. Relaxing blood vessels reduces the risk of heart attack, stroke, and kidney damage associated with hypertension.

Yes, Olmesartan Medoxomil is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200692. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 130881. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Suchen Sie patientenfreundliche Informationen?

Olmesartan Medoxomil auf PillFYI

Struktur

Schnelldaten

Formel: C29H30N6O6
Synonyme: 7

Externe Links

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.